Developing primary PCI as a national reperfusion strategy for patients with ST-elevation myocardial infarction: The UK experience

EuroIntervention

Volumn 8, Issue , 2012, Pages P99-P107

  McLenachan, James M ^a   Gray, Huon H ^b   De Belder, Mark A ^c   Ludman, Peter F ^d   Cunningham, David ^d   Birkhead, John ^d  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULANCE TRANSPORTATION; ARTICLE; BLOOD CLOT LYSIS; CLINICAL PATHWAY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEART MUSCLE REPERFUSION; HEART REHABILITATION; HUMAN; NATIONAL HEALTH SERVICE; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY MEDICAL CARE; PROPHYLAXIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TOTAL QUALITY MANAGEMENT; TREATMENT DURATION; TREATMENT OUTCOME; UNITED KINGDOM; FIBRINOLYTIC THERAPY; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH PROMOTION; HEART INFARCTION; HOSPITAL PLANNING; INTEGRATED HEALTH CARE SYSTEM; MANAGEMENT; NONBIOLOGICAL MODEL; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; REGISTER; STANDARD; TIME; TIME TO TREATMENT;

DELIVERY OF HEALTH CARE, INTEGRATED; GREAT BRITAIN; HEALTH POLICY; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HOSPITAL PLANNING; HUMANS; MODELS, ORGANIZATIONAL; MYOCARDIAL INFARCTION; ORGANIZATIONAL OBJECTIVES; PERCUTANEOUS CORONARY INTERVENTION; POLICY MAKING; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; REGISTRIES; STATE MEDICINE; THROMBOLYTIC THERAPY; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84905291859     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8SPA18     Document Type: Article

References (30)

1. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abilgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS for the DANAMI 2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. NEJM. 2003;349:733-42.
2. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. Eur Heart J. 2000;21:823-31.
3. Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, Branny M, St'asek J, Formanek P, on behalf of the 'PRAGUE' Study Group Investigators. Long-distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J. 2003;24:94-104.
4. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003:361:13-20.
5. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction. A meta-analysis. JAMA. 2000;283:2686-92.
6. Birkhead J. Where are we today? Early results from MINAP, the National Audit of Myocardial Infarction Project. Heart. 2003;89 Suppl 2:ii13-5.
7. National Infarct Angioplasty Project (NIAP) interim report. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-083061
8. Treatment of heart attack national guidance. Final report of the National Infarct Angioplasty Project (NIAP). http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/Publications PolicyAndGuidance/DH-089455
9. Sampson FC, O'Cathain C, Goodacre S. Is primary angioplasty an acceptable alternative to thrombolysis? Quantitative and qualitative study of patient and carer satisfaction. Health Expect. 2010;13:350-8.
10. Carter A, Wood S, Goodacre S, Sampson F, Stables R. Evaluation of workforce and organisational issues in establishing primary angioplasty in England. J Health Serv Res Policy. 2010;15:6-13.
11. Wailoo A, Goodacre S, Sampson F, Hernandez M, Asseburg C, Palmer S, Sculpher M, Abrams K, de Belder M, Gray H. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty project. Heart. 2010;96:668-72.
12. de Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223-5.
13. Terkelsen CJ, Lassen JF, N?rgaard BL, Gerdes JC, Poulsen SH, Bendix K, Ankersen JP, G?tzsche LB-H, R?mer FK, Nielsen TT, Andersen HR. Reduction in treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutaneous coronary intervention. Eur Heart J. 2005;26:770-7.
14. Lieu TA, Gurley RJ, Lundstrom RJ, Ray GT, Fireman BH, Weinstein MC, Parmley WW. Projected cost-effectiveness of primary angioplasty for acute myocardial infarction. JACC. 1997;30:1741-50.
15. Hartwell D, Colquitt J, Loveman E, Clegg AJ, Brodin H, Waugh N, Royle P, Davidson P, Vale L, MacKenzie L. Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation. Health Technol Assess. 2005;9:1-99.
16. Bravo Vergel Y, Palmer S, Asseburg C, Fenwick E, de Belder M, Abrams K, Sculpher M. Is primary angioplasty costeffective in the UK? Results of a comprehensive decision analysis. Heart. 2007;93:1238-43.
17. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, J?rgensen E, Marco J, Nordrehaug J-E, Ruzyllo W, Urban P, Stone GW, Wijns W. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. Eur Heart J. 2005;26:804-47.
18. How the NHS cares for patients with heart attack. Ninth public report 2010. Prepared on behalf of the MINAP steering group. http://old.rcplondon.ac.uk/clinical-standards/organisation/partnership/Documents/MINAP-Public-Report-Sept-2010.pdf
19. Coronary heart disease: national service framework for coronary heart disease-modern standards and service models. Department of Health Publication, 2000. http://www.dh.gov.uk/en/Publicationsand statistics/Publications/PublicationsPolicyAnd Guidance/DH-4094275
20. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J. 2008;29:2909-45.
21. Terkelsen CJ, Christiansen EH, S?rensen JT, Kristensen SD, Lassen JF, Thuesen L, Andersen HR, Vach W, Nielsen TT. Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time. Heart. 2009;95:362-9.
22. McLenachan J, Marley C, Machin S. A Guide to Implementing Primary Angioplasty. http://www.improvement.nhs.uk/heart/heartresources/publications.aspx
23. McLenachan JM, Machin S, Marley C. National roll-out of Primary PCI for patients with ST segment elevation myocardial infarction: an interim report. http://www.improvement.nhs.uk/heartresources/publications.aspx
24. Astin F, Closs SJ, McLenachan J, Hunter S and Priestley C. Primary angioplasty for heart attack: mismatch between expectations and reality? J Adv Nurs. 2009;65:72-83.
25. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, Andrikopoulos G, Baz JA, Betriu A, Claeys M, Danchin N, Djambazov S, Erne P, Hartikainen J, Huber K, Kala P, Klinceva M, Kristensen SD, Ludman P, Ferre JM, Merkely B, Milicic D, Morais J, Noc M, Opolski G, Ostojic M, Radovanovic D, De Servi S, Stenestrand U, Studencan M, Tubaro M, Vasiljevic Z, Weidinger F, Witkowski A, Zeymer U; European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31:943-57.
26. Myocardial Ischaemia National Audit Project. How the NHS cares for patients with heart attack. Tenth Public Report 2011. Prepared on behalf of the MINAP Steering Group. http://www.ucl. ac.uk/nicor/audits/minap/publicreports/pdfs/minappublic report2011
27. Widimsky P, Fajadet J, Danchin N, Wijns W. "Stent 4 Life" targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC working group on acute cardiac care. EuroIntervention. 2009;4:555-7.
28. Knot J, Widimsky P, Wijns W, Stenestrand U, Kristensen SD, Van'T Hof A, Weidinger F, Janzon M, Nörgaard BL, Soerensen JT, van de Wetering H, Thygesen K, Bergsten PA, Digerfeldt C, Potgieter A, Tomer N, Fajadet J. How to set up an effective national primary angioplasty network: lessons learned from five European countries. EuroIntervention. 2009;5:301-9.
29. Krumholz HM, Bradley EH, Nallamothu BK, Ting HH, Batchelor WB, Kline-Rogers E, Stern AF, Byrd JR, Brush JE Jr. A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-To-Balloon: An Alliance for Quality. JACC Cardiovasc Interv. 2008;1:97-104.
30. Terkelsen CJ. Jensen LO, Tilsted HH, Thaysen R, Ravkilde J, Johnsen SP, Trautner S, Andersen HR, Thuesen L, Lassen JF. Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-segment elevation myocardial infarction. Circ Cardiovasc Interv. 2011;4:570-6.